NVO → $100.00 by Oct 29, 2026.

I entered today. My target : 100 Novo Nordisk has disappointed investors for a while, and the market has lost confidence. Look at today’s drop. That doesn’t make me bearish - it makes me interested. The obesity market is far from saturated, and while competition has intensified, Novo remains one of the global leaders with exceptional scientific expertise, a strong balance sheet, and a long track record of execution. There will inevitably be setbacks, but I believe management is making …